Skye Bioscience, Inc.

Skye Bioscience, Inc.

Biotechnology • Healthcare • San Diego, CA, United States • SKYE (NGM)

Skye Bioscience, Inc., a clinical stage biopharmaceutical company, focuses on developing molecules that modulate G protein-coupled receptors (GPCRs) to treat obesity, overweight, and metabolic diseases. Its lead product candidate is nimacimab, a peripherally restricted negative allosteric modulating antibody targeting cannabinoid receptor 1, a key GPCR involved in metabolic regulation. The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January 2021. The company is headquartered in San Diego, California.

858 410 0266 11250 El Camino Real, San Diego, CA 92130, United States

Stock Performance (90 Days)

Data through Dec 30, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

SKYE ALERT: Securities Fraud Class Action Launched Against Skye Bioscience, Inc. - January 16, 2026 Deadline - ACCESS Newswire
ACCESS Newswire • Dec 30
Lost Money on Skye Bioscience, Inc.(SKYE)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm - PR Newswire
PR Newswire • Dec 29
Levi & Korsinsky Reminds Skye Bioscience, Inc. Investors of - GlobeNewswire
GlobeNewswire • Dec 26
Portnoy Law Firm Announces Class Action on Behalf of Skye Bioscience, Inc. Investors - GlobeNewswire
GlobeNewswire • Dec 29
SHAREHOLDER ACTION NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye Bioscience - PR Newswire
PR Newswire • Dec 23

Other Biotechnology Companies

View All →
CODEXIS, INC. logo Codexis, Inc.
1 layoff tracked
$144.5M market cap
VERTEX PHARMACEUTICALS INC / MA logo Vertex Pharmaceuticals Inc. / MA
$118.68B market cap
REGENERON PHARMACEUTICALS, INC. logo Regeneron Pharmaceuticals, Inc.
$82.72B market cap
ALNYLAM PHARMACEUTICALS, INC. logo Alnylam Pharmaceuticals, Inc.
$52.92B market cap
ARGENX SE logo Argenx SE
$52.62B market cap
INSMED Inc logo Insmed Inc.
$37.61B market cap

Frequently Asked Questions

Has Skye Bioscience, Inc. had layoffs?
No layoff events have been recorded for Skye Bioscience, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does Skye Bioscience, Inc. have?
Skye Bioscience, Inc. has approximately 16 employees.
What industry is Skye Bioscience, Inc. in?
Skye Bioscience, Inc. operates in the Biotechnology industry, within the Healthcare sector.
Is Skye Bioscience, Inc. a publicly traded company?
Yes, Skye Bioscience, Inc. is publicly traded under the ticker symbol SKYE on the NGM. The company has a market capitalization of approximately $0.02 billion.
Where is Skye Bioscience, Inc. headquartered?
Skye Bioscience, Inc. is headquartered in San Diego, CA, United States at 11250 El Camino Real, San Diego, CA 92130, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.